Allspring Global Investments
MED icon

Allspring Global Investments’s Medifast MED Stock Holding History

Allspring Global Investments’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-38
Closed -$727 – 2145
2024
Q3 		$727 Sell
38
-5,018
-99% -$96.7K ﹤0.01% 2358
2024
Q2 		$110K Sell
5,056
-37,837
-88% -$1.01M ﹤0.01% 1834
2024
Q1 		$1.64M Buy
42,893
+30,610
+249% +$1.48M ﹤0.01% 1247
2023
Q4 		$826K Buy
12,283
+3,299
+37% +$230K ﹤0.01% 1385
2023
Q3 		$672K Buy
8,984
+2,188
+32% +$194K ﹤0.01% 1459
2023
Q2 		$626K Sell
6,796
-9,418
-58% -$838K ﹤0.01% 1516
2023
Q1 		$1.68M Sell
16,214
-5,313
-25% -$589K ﹤0.01% 1297
2022
Q4 		$2.48M Buy
21,527
+10,433
+94% +$1.21M ﹤0.01% 1183
2022
Q3 		$1.2M Sell
11,094
-200
-2% -$28.7K ﹤0.01% 1385
2022
Q2 		$2.04M Sell
11,294
-4,482
-28% -$802K ﹤0.01% 1220
2022
Q1 		$2.69M Sell
15,776
-2,931
-16% -$553K ﹤0.01% 1358
2021
Q4 		$3.92M Buy
+18,707
New +$3.87M ﹤0.01% 1260

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Allspring Global Investments's MED Position: Q4 2024 in Review

Allspring Global Investments sold out of Medifast (MED) in Q4 2024, closing a stake of 38 shares — an estimated $727 sold.

Allspring Global Investments first reported a position in MED in Q4 2021 and held it in 12 quarters. The position peaked at $3.92M in Q4 2021. 129 funds tracked by Wall St. Rank hold MED as of Q4 2024.

  • Allspring Global Investments reported no remaining Medifast position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 38 Medifast shares in Q4 2024, an estimated $727.
  • Allspring Global Investments first reported a position in Medifast in Q4 2021 and held it in 12 quarters.
  • Allspring Global Investments's Medifast position peaked at $3.92M in Q4 2021.
  • 129 funds tracked by Wall St. Rank held Medifast as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.